Answers are grounded in this paper and cite their sources.
BACKGROUND: Upper gastrointestinal (UGI) involvement occurs in about 13% of patients with Crohn's disease (CD) and is variably defined across guidelines, which complicates prognosis. We mapped adult data on prognostic factors and outcomes in UGI‑CD and identified evidence gaps. METHODS: A comprehensive search strategy was applied to MEDLINE, Embase, and Cochrane Central through November 26, 2025. We included studies reporting prognostic factors in patients with UGI-CD. We synthesized evidence across 3 domains: (1) patient and disease characteristics associated with UGI involvement at diagnosis, (2) the comparative prognosis of UGI-CD vs non-UGI disease, and (3) among patients with UGI-CD, factors associated with long-term adverse outcomes. Findings were synthesized narratively. RESULTS: From 3297 screened records, 732 underwent full text assessment, and 43 primary studies were included. A total of 101 prognostic factor-outcome relationships were identified. In domain 1 (patient and disease characteristics associated with UGI involvement at diagnosis), younger age at onset was the most consistently reported factor associated with UGI involvement. In domain 2 (comparative prognosis vs non-UGI disease), studies evaluating pooled L4 disease frequently associated UGI involvement at diagnosis with higher surgical risk, incident stricture development, and adverse long-term outcomes. However, studies that distinguished anatomic subtypes suggested that risk is not uniform: jejunal/proximal small bowel disease generally followed a more aggressive course, whereas esophagogastroduodenal-limited disease appeared to have a comparatively more favorable prognosis. In domain 3 (among patients with UGI-CD, factors associated with long-term adverse outcomes), a higher Simple Endoscopic Score for Crohn's Disease was associated with subsequent surgery in a duodenal stricture cohort on univariable analysis; an independent prognostic effect was not established. CONCLUSIONS: The available literature suggests that prognosis in UGI-CD is not uniform. Jejunal/proximal small bowel disease appears to follow a more aggressive course than esophagogastroduodenal-limited disease, although interpretation is limited by predominantly retrospective designs, heterogeneous definitions, and inconsistent adjustment for confounders.
No takes yet. Share an insight, caveat, or question.
Elzaanoun et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: